Ajooni Biotech enters into strategic agreement with IFFCO KISAN Sanchar; stock hits 52-week high

9 Feb 2022 , 12:06 PM

NSE listed Ajooni Biotech Limited, a pioneer, innovator and leader in the production of animal feed and IFFCO KISAN Sanchar Ltd (IKSL) have entered into a strategic and exclusive agreement, whereby ABL would manufacture Feed Supplements for IKSL on a pan India basis. This strategic arrangement would diversify ABL products stream from mere cattle feeds business towards high-value supplement business.

The company will have to set up a new state of the art manufacturing facilities to cater to the supplies of IKSL.

Reacting to this news, shares hit a 52-week on the NSE at Rs82 on Tuesday’s trade.

Also, the company will have to create a nationwide logistic network to execute the orders through the already established dealer and distributor
network of IKSL.

Also, the company is in the advanced stage of Research for the Development of new animal health care products i.e. Mineral Mixhire, Liver tonic and other unique products of Veterinary supplements and will be launched jointly with IKSL in the market within the next few months.

The company’s priorities are quality, safety, innovations in the production process, as well as excellent services provided to customers.